MicroBioGen

MicroBioGen stands as a global leader in pioneering yeast biotechnology, driving advancements across a wide spectrum of industrial applications. Specializing in the development of superior yeast biocatalysts, MicroBioGen's innovative platform technology supports products valued at over US$1 trillion annually. With a commitment to sustainability, MicroBioGen collaborates with partners, customers, and shareholders to build a more sustainable future through proprietary, high-tech development programs.

Located at 78 Waterloo Rd, Level 4, New South Wales MicroBioGen, AU, MicroBioGen is dedicated to advancing the industry standards in biofuel production with its highly advanced Saccharomyces cerevisiae yeast products, notably the Novozymes Innova series. The company is also in the final stages of developing a groundbreaking yeast product for 2nd generation biofuels in collaboration with a major global corporate, supported by an $8M optimisation program from ARENA (The Australian Renewable Energy Agency).

MicroBioGen's unique platform technology extends beyond biofuels to encompass human food, animal feed, enzymes, protein vectors, probiotics, biochemicals, and even space exploration. The team at MicroBioGen is continuously innovating to meet the evolving needs of various sectors. We invite the management of MicroBioGen to create a customized and exclusive company showcase and product listing on our platform to further highlight their expertise and innovations.